Search This Blog

Monday, February 22, 2010

Reviewers urge Glaxo's Avandia come off market

Via Reuters, a possible recall to GlaxoSmithKline PLC's diabetes drug Avandia? Only time will tell........

" WASHINGTON (Reuters) - Two U.S. drug safety reviewers have recommended that GlaxoSmithKline PLC's diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, according to documents released on Saturday.

The Food and Drug Administration will again ask an advisory panel to consider the risks of the drug, Glaxo's second biggest-selling product before questions about a possible link to heart attacks emerged in 2007."

No comments:

Post a Comment